Y-mAbs secures marketing approval for Danyelza injection in Brazil
Danyelza is said to be a recombinant humanised, monoclonal antibody that targets the ganglioside GD2, highly expressed in…
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
24 May 23
Danyelza is said to be a recombinant humanised, monoclonal antibody that targets the ganglioside GD2, highly expressed in…
24 May 23
ModeX will gain access to Nona Bioscience’s fully human Harbour Mice platforms to discover monoclonal antibodies that will…
24 May 23
In the 12-month period ending in December 2022, over 79,000 people in the U.S. were reported to have…
24 May 23
INO-3107 is an investigational DNA medicine candidate designed to elicit a targeted T cell response against HPV-6 and…
23 May 23
Under the terms of the agreement, UAE-based Genpharm will distribute IMCIVREE to patients in GCC countries for the…
23 May 23
Vafseo is an oral hypoxia-inducible factor prolyl hydroxylase (HIF-PH) inhibitor to treat symptomatic anaemia related to chronic kidney…
23 May 23
ReNAgade has developed an extensive and complementary platform that integrates its exclusive delivery technologies, such as innovative lipid…
23 May 23
Platform-as-a-service now broadly available to help customers achieve healthcare data integration
23 May 23
Phase 2 study shows 26 weeks of treatment with twice-daily 60 mg dose of BMS-986278 resulted in a…
22 May 23
Vyjuvek is a genetically modified herpes-simplex virus, engineered in a laboratory to treat DEB, a serious rare genetic…